Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy (IgAN), a rare, progressive chronic kidney disease
Coverage of CGHS cities has expanded from 25 cities in 2014 to 80 in 2023
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
The business and product range of Ipca and that of Unichem complements each others business and product range
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
To enable company to be future-ready by tapping potential in CDMO space
Subscribe To Our Newsletter & Stay Updated
